(URGN) Urogen Pharma complete technical analysis [charts+indicators] | Buy/Sell Urogen Pharma | (URGN) share price targets
Complete technical analysis of Urogen Pharma (URGN) by charts plus indicators, forecast predictions and share price targets for Urogen Pharma (URGN)
Urogen Pharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-03-25 View latest technical analysis
10 day averaged volume of Urogen Pharma is 511910
| Date | Daily Closing Price | Open | High | Low | Volume |
| 25 Mon Mar 2024 | 16.66 | 16.19 | 18.23 | 16.00 | 1.749 times |
| 22 Fri Mar 2024 | 15.76 | 14.89 | 16.17 | 14.73 | 4.403 times |
| 21 Thu Mar 2024 | 14.94 | 14.88 | 15.16 | 14.57 | 0.782 times |
| 20 Wed Mar 2024 | 14.96 | 14.98 | 15.18 | 14.31 | 0.401 times |
| 19 Tue Mar 2024 | 15.02 | 14.39 | 15.23 | 14.18 | 0.536 times |
| 18 Mon Mar 2024 | 14.50 | 14.50 | 14.58 | 13.83 | 0.575 times |
| 15 Fri Mar 2024 | 14.46 | 14.49 | 14.84 | 13.86 | 0.795 times |
| 14 Thu Mar 2024 | 14.33 | 16.77 | 16.89 | 14.14 | 1.251 times |
| 13 Wed Mar 2024 | 17.47 | 17.83 | 17.83 | 16.88 | 0.243 times |
| 12 Tue Mar 2024 | 17.62 | 17.16 | 17.75 | 16.84 | 0.482 times |
My analysis of stock is bearish for shortterm, and stock might move down till 15.3 or till 13.5. Use a stoploss of 16.81 and if the stock hits stoploss, then it can shoot up till 18.33
Share price targets for Urogen Pharma (URGN)
| Target Type | Value |
| Downside Target | 10.90 |
| Downside Target | 12.76 |
| Downside Target | 13.40 |
| Downside Target | 13.78 |
| Downside Target | 15.40 |
| Downside Target | 16.00 |
| Upside Target | 17.47 |
| Upside Target | 18.23 |
| Upside Target | 18.29 |
| Upside Target | 18.63 |
| Upside Target | 18.72 |
| Upside Target | 19.87 |
Intraday share price targets for Urogen Pharma (URGN)
| Target Type | Value |
| Downside Intraday Target | 15.7 |
| Downside Intraday Target | 14.73 |
| Upside Intraday Target | 17.93 |
| Upside Intraday Target | 19.19 |
| Upside Intraday Target | 16.96 |
Weekly technical analysis of Urogen Pharma (URGN)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 25 Mon Mar 2024 | 16.66 | 16.19 | 18.23 | 16.00 | 0.261 times |
| 22 Fri Mar 2024 | 15.76 | 14.50 | 16.17 | 13.83 | 2.028 times |
| 15 Fri Mar 2024 | 14.46 | 18.10 | 18.29 | 13.86 | 1.269 times |
| 08 Fri Mar 2024 | 17.99 | 17.90 | 18.63 | 17.47 | 1.262 times |
| 01 Fri Mar 2024 | 17.77 | 17.05 | 18.72 | 16.30 | 1.409 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Urogen Pharma (URGN)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 25 Mon Mar 2024 | 16.66 | 17.32 | 18.63 | 13.83 | 1.045 times |
| 29 Thu Feb 2024 | 18.33 | 15.76 | 19.87 | 15.40 | 1.398 times |
| 31 Wed Jan 2024 | 15.70 | 14.97 | 16.45 | 13.40 | 0.833 times |
| 29 Fri Dec 2023 | 15.00 | 13.25 | 16.32 | 12.76 | 1.098 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Urogen Pharma (URGN)
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Urogen Pharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Urogen Pharma in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Urogen Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Urogen Pharma in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Urogen Pharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 15.58 and Urogen Pharma (URGN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Urogen Pharma (URGN) stock. Volume based technical analysis of Urogen Pharma (URGN) stock is negative.
Urogen Pharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Urogen Pharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Urogen Pharma in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Urogen Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Urogen Pharma in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Urogen Pharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 15.58 and Urogen Pharma (URGN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Urogen Pharma (URGN) stock. Volume based technical analysis of Urogen Pharma (URGN) stock is negative.
Urogen Pharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.